Gary Druskovich, MD, MBA

Retired Regional President/CEO MetroWest Ascension Michigan

📍 United States🔄 Updated September 2026💼 3 investments📅 8 years investing🗓 Last invested Sep 2023
Angel investor🌍 United States
3
Total investments
0
Early stage
0
Mid stage
0
Late stage
8y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
Sep 2023
IrishAngels is a Notre Dame inspired angel investing group for experienced operators, executives, and founders who want to invest thoughtfully in early-stage companies and stay meaningfully involved beyond the check. Our investors share a common foundation through the University of Notre Dame and a belief that early-stage investing works best when capital and community come together. We invest primarily at the seed stage across B2B and consumer technology, partnering closely with founders and co-investors we respect. Since 2012, IrishAngels has deployed over $65 million into more than 100 companies. More importantly, we’ve built an active, engaged community of over 250 angels who bring operating experience, pattern recognition, and long-term perspective to the companies we support. IrishAngels aims to be a trusted partner to founders and a credible co-investor to the broader venture ecosystem. Headquartered in Chicago, with members across the U.S.
Board Member
Aug 2018
WMed is committed to excellence and health equity through transformative medical education, high-quality, patient- and family-centered care, innovative research, and community partnerships within a just culture of diversity, equity, inclusion, and belonging. Our vision is health equity for all in Southwest Michigan through innovation in the practice and study of medicine. The medical school is a collaboration of Western Michigan University and Kalamazoos two teaching health systems, Ascension Borgess and Bronson Healthcare. The medical school is a private nonprofit corporation supported by private gifts, clinical revenues, research activities, tuition, and endowment income. Building upon a $100 million foundational gift in 2011, WMed is a recipient of the Empowering Futures Gift, a philanthropic commitment of $300 million to support the mission of the medical school. WMed contributes to the economic vitality of Southwest Michigan through the services we provide as well as the creation of 1,600 new jobs and an annual estimated economic impact of $353 million in Kalamazoo and Calhoun counties. WMed is fully accredited by the Liaison Committee on Medical Education and the Higher Learning Commission. The medical school offers a comprehensive, innovative four-year Doctor of Medicine degree program and two Master of Science degree programs in Biomedical Sciences and Medical Engineering. We train physicians in 10 residencies and five fellowships accredited by the Accreditation Council for Graduate Medical Education. To support our educational mission, we have Joint Accreditation for interprofessional continuing education, which incorporates accreditation by the Accreditation Council for Continuing Medical Education. WMed is building upon Kalamazoo’s century-long foundation of drug discovery and medical device development with a strategic investment in clinical, laboratory, community, and educational research.
Experience · 3 entries
All (3)
Investments (3)
Board (2)
2023
Angel Investor
Sep 2023
IrishAngels is a Notre Dame inspired angel investing group for experienced operators, executives, and founders who want to invest thoughtfully in early-stage companies and stay meaningfully involved beyond the check. Our investors share a common foundation through the University of Notre Dame and a belief that early-stage investing works best when capital and community come together. We invest primarily at the seed stage across B2B and consumer technology, partnering closely with founders and co-investors we respect. Since 2012, IrishAngels has deployed over $65 million into more than 100 companies. More importantly, we’ve built an active, engaged community of over 250 angels who bring operating experience, pattern recognition, and long-term perspective to the companies we support. IrishAngels aims to be a trusted partner to founders and a credible co-investor to the broader venture ecosystem. Headquartered in Chicago, with members across the U.S.
2018
Board Member
Aug 2018
WMed is committed to excellence and health equity through transformative medical education, high-quality, patient- and family-centered care, innovative research, and community partnerships within a just culture of diversity, equity, inclusion, and belonging. Our vision is health equity for all in Southwest Michigan through innovation in the practice and study of medicine. The medical school is a collaboration of Western Michigan University and Kalamazoos two teaching health systems, Ascension Borgess and Bronson Healthcare. The medical school is a private nonprofit corporation supported by private gifts, clinical revenues, research activities, tuition, and endowment income. Building upon a $100 million foundational gift in 2011, WMed is a recipient of the Empowering Futures Gift, a philanthropic commitment of $300 million to support the mission of the medical school. WMed contributes to the economic vitality of Southwest Michigan through the services we provide as well as the creation of 1,600 new jobs and an annual estimated economic impact of $353 million in Kalamazoo and Calhoun counties. WMed is fully accredited by the Liaison Committee on Medical Education and the Higher Learning Commission. The medical school offers a comprehensive, innovative four-year Doctor of Medicine degree program and two Master of Science degree programs in Biomedical Sciences and Medical Engineering. We train physicians in 10 residencies and five fellowships accredited by the Accreditation Council for Graduate Medical Education. To support our educational mission, we have Joint Accreditation for interprofessional continuing education, which incorporates accreditation by the Accreditation Council for Continuing Medical Education. WMed is building upon Kalamazoo’s century-long foundation of drug discovery and medical device development with a strategic investment in clinical, laboratory, community, and educational research.
Member of the Board
Feb 2018
West Michigan Cancer Center (WMCC) is changing the tide on cancer. WMCC is an ambulatory, stand alone cancer center. We are treating, beating and curing cancer more than ever before, and helping patients move beyond it so it doesn’t maintain a grip on their lives. We have the technological resources, clinical skill, support services, and experience to best meet your individual challenge, which explains why more people are referred and treated here than anywhere else in the region. If you or a loved one has been diagnosed with cancer, plan to fight it and fight to win. Together, we win.
Investment activity
2018–2023 · 3 investments
2018220231
Recent (last 2 years)Earlier